NCT07525804

Brief Summary

This single-center randomized controlled trial evaluated whether a structured flipped-discharge education model improves discharge readiness and short-term outcomes compared with routine discharge education in adults with malignant obstructive jaundice managed with percutaneous transhepatic cholangiodrainage (PTCD). Participants were randomized 1:1 to flipped-discharge education or routine education and followed for approximately 28 days after discharge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 13, 2026

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

March 29, 2026

Last Update Submit

April 7, 2026

Conditions

Keywords

PTCDPercutaneous Transhepatic CholangiodrainageFlipped-Discharge EducationDischarge ReadinessSelf-Care Capacity

Outcome Measures

Primary Outcomes (1)

  • Readiness for hospital discharge as assessed by the Readiness for Hospital Discharge Scale (RHDS)-Adult Form

    The Readiness for Hospital Discharge Scale (RHDS)-Adult Form measures patient readiness to return home following acute care hospitalization. According to the scale developer, the RHDS score is calculated by adding the item scores and dividing by the number of items to obtain a mean item score. Possible scores range from 0 to 10, with higher scores indicating greater readiness for hospital discharge and therefore a better outcome.

    Approximately 28 days after discharge

Secondary Outcomes (3)

  • Family functioning as assessed by the Family APGAR

    Approximately 28 days after discharge

  • Self-care agency as assessed by the Exercise of Self-Care Agency Scale (ESCA)

    Approximately 28 days after discharge

  • Physical health quality of life as assessed by the World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF)

    Approximately 28 days after discharge

Study Arms (2)

Flipped-Discharge Education

EXPERIMENTAL

Participants received a structured flipped-discharge education program, including staged pre-discharge training, individualized nursing planning, and weekly telehealth follow-up during the first 4 weeks after discharge.

Behavioral: Flipped-Discharge Education Model

Routine Education

ACTIVE COMPARATOR

Participants received routine discharge education, including standard written and verbal PTCD catheter care instructions and post-discharge precautions.

Behavioral: Routine Discharge Education

Interventions

Standard discharge education delivered by healthcare providers, including self-guided review of health manuals, verbal explanation of PTCD catheter care, and a checklist of post-discharge precautions.

Routine Education

Structured education delivered by a multidisciplinary team, including PTCD catheter-care training, individualized discharge planning, and weekly telehealth follow-up during the first 4 weeks after discharge.

Flipped-Discharge Education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older
  • Diagnosed with malignant obstructive jaundice
  • Undergoing percutaneous transhepatic cholangiodrainage (PTCD)
  • Clear indication for PTCD, such as unresectable biliary obstruction
  • Preserved consciousness and ability to communicate
  • Provided written informed consent

You may not qualify if:

  • Psychiatric disorders
  • Active severe infection
  • Hematologic disease
  • Language barriers
  • Anticipated loss to follow-up
  • Disease progression, death during the study period, or voluntary withdrawal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foshan First People's Hospital

Foshan, Guangdong, 528000, China

Location

Study Officials

  • Xia Xiang, BS

    First People's Hospital of Foshan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the educational nature of the intervention, participants and educators were not blinded. Outcome assessors and data analysts were blinded to group assignment.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

March 29, 2026

First Posted

April 13, 2026

Study Start

December 1, 2023

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

April 13, 2026

Record last verified: 2026-04

Locations